ArticleBMC cancer2017
Life tables for global surveillance of cancer survival (the CONCORD programme): data sources and methods.
Article in BMC cancer, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
25 citing papers in PubMed.
- Impact of the COVID-19 pandemic on cancer incidence, stage, mortality, and short-term survival in Ireland: a population-based analysis.ESMO real world data and digital oncology · 2026Article
- Trends in net survival from cervical cancer in a Brazilian state with medium Human Development Index.Scientific reports · 2025Article
- The impact of life tables on age standardized net survival of real-life example databases.BMC medical research methodology · 2025Article
- Cancer Prevalence Projections in Japan and Decomposition Analysis of Changes in Cancer Burden, 2020-2050: A Statistical Modeling Study.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2023Article
- Global survival trends for brain tumors, by histology: Analysis of individual records for 67,776 children diagnosed in 61 countries during 2000-2014 (CONCORD-3).Neuro-oncology · 2023Article
- Global survival trends for brain tumors, by histology: analysis of individual records for 556,237 adults diagnosed in 59 countries during 2000-2014 (CONCORD-3).Neuro-oncology · 2023Article
- Determining Fitness for Use of SEER Cause-Specific Cause of Death in Analyses of Cause-Specific Survival.Journal of registry management · 2022Article
- Socioeconomic gaps over time in colorectal cancer survival in England: flexible parametric survival analysis.Journal of epidemiology and community health · 2021Article
- Article
- Net survival for colorectal cancer in Cuiabá and Várzea Grande (state of Mato Grosso), Brazil.Ecancermedicalscience · 2021Article
- Incidence, Mortality, and Survival Trends of Primary CNS Tumors in Cali, Colombia, From 1962 to 2019.JCO global oncology · 2020Article
- Global Trends in Survival From Astrocytic Tumors in Adolescents and Young Adults: A Systematic Review.JNCI cancer spectrum · 2020Article
- Predicting Life Expectancy for Older Adults with Cancer in Clinical Practice: Implications for Shared Decision-making.Current oncology reports · 2019Review
- Deprivation-specific life tables using multivariable flexible modelling - trends from 2000-2002 to 2010-2012, Portugal.BMC public health · 2019Article
- Expression and significance of LncRNA MNX1-AS1 in non-small cell lung cancer.OncoTargets and therapy · 2019Article
- Disparities in breast cancer survival in the United States (2001-2009): Findings from the CONCORD-2 study.Cancer · 2017Article
- Population-based cancer survival in the United States: Data, quality control, and statistical methods.Cancer · 2017Article
- Disparities in ovarian cancer survival in the United States (2001-2009): Findings from the CONCORD-2 study.Cancer · 2017Article
- Prostate cancer survival in the United States by race and stage (2001-2009): Findings from the CONCORD-2 study.Cancer · 2017Article
- Cervical cancer survival in the United States by race and stage (2001-2009): Findings from the CONCORD-2 study.Cancer · 2017Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
backgroundWe set out to estimate net survival trends for 10 common cancers in 279 cancer registry populations in 67 countries around the world, as part of the CONCORD-2 study. Net survival can be interpreted as the proportion of cancer patients who survive up to a given time, after eliminating the impact of mortality from other causes (background mortality). Background mortality varies widely between populations and over time. It was therefore necessary to construct robust life tables that accurately reflected the background mortality in each of the registry populations.
methodsLife tables of all-cause mortality rates by single year of age and sex were constructed by calendar year for each population and, when possible, by racial or ethnic sub-groups. We used three different approaches, based on the type of mortality data available from each registry. With death and population counts, we adopted a flexible multivariable modelling approach. With unsmoothed mortality rates, we used the Ewbank relational method. Where no data were available from the registry or a national statistical office, we used the abridged UN Population Division life tables and interpolated these using the Elandt-Johnson method. We also investigated the impact of using state- and race-specific life tables versus national race-specific life tables on estimates of net survival from four adult cancers in the United States (US).
resultsWe constructed 6,514 life tables covering 327 populations. Wide variations in life expectancy at birth and mortality by age were observed, even within countries. During 1995-99, life expectancy was lowest in Nigeria and highest in Japan, ranging from 47 to 84 years among females and 46 to 78 years among males. During 2005-09, life expectancy was lowest in Lesotho and again highest in Japan, ranging from 45 to 86 years among females and 45 to 80 years among males. For the US, estimates of net survival differed by up to 4% if background mortality was fully controlled with state- and race-specific life tables, rather than with national race-specific life tables.
conclusionsBackground mortality varies worldwide. This emphasises the importance of using population-specific life tables for geographic and international comparisons of net survival.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.